Health TrialsbyHealthPanel

The Effect of Progressive Muscle Relaxation Exercises on Fatigue, Dyspnea, and Respiratory Function in Patients With Systemic Sclerosis

ConditionSystemic Sclerosis (SSc)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Gaziantep

About this trial

This study aims to evaluate the effects of progressive muscle relaxation exercises on fatigue, dyspnea, and respiratory function in patients with systemic sclerosis. Participants will be assessed before and after the intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Progressive Muscle Relaxation Exercise

    Behavioral

    Participants in the intervention group will receive progressive muscle relaxation exercises according to the study protocol. The intervention will be administered in addition to standard care.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Progressive Muscle Relaxation Exercise GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Fatigue severity measured by the FACIT-Fatigue Scale

Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Scale. Changes in fatigue scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

Time frame
Baseline and 4 weeks after the intervention
2

Dyspnea severity measured by the Dyspnea-12 (D-12) Scale

Dyspnea will be assessed using the Dyspnea-12 (D-12) Scale. Changes in dyspnea scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

Time frame
Baseline and 4 weeks after the intervention

Secondary outcomes

1

Respiratory function measured by forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)

Respiratory function will be assessed using spirometry, including forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). Changes in FEV1 and FVC from baseline to post-intervention assessment will be evaluated between the intervention and control groups.

Time frame
Baseline and 4 weeks after the intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Gaziantep

Lead sponsor

Source ClinicalTrials.gov
Apply now